ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer Care
NIJMEGEN, Netherlands, April 17, 2026 /PRNewswire/ -- ScreenPoint Medical, a leader in artificial intelligence solutions for breast cancer detection and risk assessment, today announced $14 million in new funding from existing investors, global software investor Insight Partners and...
View original →